Cipla Limited
CIPLA
Pozycja w akcjach
#1816
Cipla Limited, along with its associated entities, operates as a global... Cipla Limited, along with its associated entities, operates as a global pharmaceutical enterprise, specializing in the creation and distribution of a wide array of medicinal products. Its extensive portfolio includes both active pharmaceutical ingredients (APIs) and a diverse range of finished formulations, addressing numerous therapeutic areas such as cardiovascular diseases, metabolic disorders, HIV, respiratory conditions, urology, oncology, pediatric health, infectious diseases, critical care, hepatitis, women's health, ophthalmology, and neuropsychiatry. The company maintains a strong focus on respiratory treatments, offering various inhalers, nasal sprays, injectables, and biosimilars. Cipla has also forged significant partnerships, including a licensing arrangement with Merck & Co., Inc. for the manufacturing and commercialization of the investigational oral antiviral drug Molnupiravir, and a separate license agreement with Eli Lilly and Company for baricitinib, indicated for COVID-19. Furthermore, it collaborates with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for Molnupiravir's clinical trials. Established in 1935, Cipla's corporate headquarters are located in Mumbai, India.
Cena akcji
$14.61
Kapitalizacja rynkowa
$11.80B
Zmiana (1 dzień)
-0.12%
Zmiana (1 rok)
-18.47%
Kraj
IN
Handel Cipla Limited (CIPLA)
Kategoria
Healthcare
Historia stopy dywidendy dla Cipla Limited (CIPLA)
Stopa dywidendy (TTM) dla Cipla Limited (symbol akcji: CIPLA) na dzień 2024-03-31 wynosi: 0.57%
Średnia stopa dywidendy z ostatnich 5 lat: 0.50%
Średnia stopa dywidendy z ostatnich 5 lat: 0.50%
Historia stopy dywidendy dla Cipla Limited (CIPLA) od 2004 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| 2026 (TTM) | 0.98% | 8.89% |
| 2025 | 0.90% | 57.89% |
| 2024 | 0.57% | 1.79% |
| 2023 | 0.56% | 14.29% |
| 2022 | 0.49% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | 1.66% | 191.23% |
| 2019 | 0.57% | 62.86% |
| 2018 | 0.35% | 2.94% |
| 2017 | 0.34% | -12.82% |
| 2016 | 0.39% | 39.29% |
| 2015 | 0.28% | -46.15% |
| 2014 | 0.52% | 0.00% |
| 2013 | 0.52% | -21.21% |
| 2012 | 0.66% | -24.14% |
| 2011 | 0.87% | 50.00% |
| 2010 | 0.58% | -36.26% |
| 2009 | 0.91% | 0.00% |
| 2008 | 0.91% | 7.06% |
| 2007 | 0.85% | 60.38% |
| 2006 | 0.53% | -54.70% |
| 2005 | 1.17% | 37.65% |
| 2004 | 0.85% | 0.00% |
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 0.00% |
DE
|
|
| 0.00% |
DE
|
|
| 0.00% |
JP
|
|
| 0.00% |
CH
|
|
| 0.91% |
IN
|
